These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6412368)

  • 1. [Some economic considerations: the cost and rentability of rehabilitation].
    Simorre R
    Soins Cardiol; 1983 May; (3):41-2. PubMed ID: 6412368
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rehabilitation of the coronary patient. Secondary prevention. A document of the Working Group on Cardiac Rehabilitation of the Sociedad Española de Cardiología].
    Rev Esp Cardiol; 1995 Oct; 48(10):643-9. PubMed ID: 7481032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics of cardiac rehabilitation and lifestyle modification: a review of literature.
    Lee AJ; Strickler GK; Shepard DS
    J Cardiopulm Rehabil Prev; 2007; 27(3):135-42. PubMed ID: 17558193
    [No Abstract]   [Full Text] [Related]  

  • 4. How much do the benefits cost? Effects of a home-based training programme on cardiovascular fitness, quality of life, programme cost and adherence for patients with coronary disease.
    Salvetti XM; Oliveira JA; Servantes DM; Vincenzo de Paola AA
    Clin Rehabil; 2008; 22(10-11):987-96. PubMed ID: 18955430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac rehabilitation: Cost and care effective.
    Stone J
    Can J Cardiol; 2004 Oct; 20(12):1256-7. PubMed ID: 15494779
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and economic cost-benefit relations in treatment of patients with coronary heart disease].
    Höher M; Hombach V
    Z Kardiol; 1998; 87 Suppl 2():8-19. PubMed ID: 9827456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive cardiac rehabilitation: is it cost-effective?
    Oldridge NB
    Eur Heart J; 1998 Nov; 19 Suppl O():O42-50. PubMed ID: 9857950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Position of the German Society for Prevention and Rehabilitation in Vascular Disease, DGPR on the study under the Health and Pension Insurance Scheme's Recommendation on Outpatient/Inpatient Rehabilitation: A. vom Orde et al., "Outcomes of cardiac rehabilitation treatment and cost-effectiveness relations--A comparison between inpatient and outpatient rehabilitation programmes"].
    Held K;
    Rehabilitation (Stuttg); 2004 Apr; 43(2):123-4. PubMed ID: 15160704
    [No Abstract]   [Full Text] [Related]  

  • 9. [Outcomes of cardiac rehabilitation treatment and cost-effectiveness relations--A comparison between inpatient and outpatient rehabilitation programmes].
    Vom Orde A; Schott T; Iseringhausen O
    Rehabilitation (Stuttg); 2002; 41(2-3):119-29. PubMed ID: 12007036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac rehabilitation after coronary artery bypass graft surgery: urgently needed!
    Drory Y
    Isr Med Assoc J; 2001 Jun; 3(6):427-9. PubMed ID: 11433636
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and economic considerations of coronary heart disease: a managed care approach. Proceedings based on presentations from two conferences, Cardiovascular Event Reduction: Defining the Role of HMG Therapy in Managed Care, held November 14-16, 1997 in Philadelphia, and Pharmacoeconomics & Outcomes Issues of Lipid Therapy, held November 5-7, 1997 in Orlando.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S168-233. PubMed ID: 10180343
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive cardiac rehabilitation: a cost assessment based on a randomized clinical trial.
    Kruse M; Hochstrasser S; Zwisler AD; Kjellberg J
    Int J Technol Assess Health Care; 2006; 22(4):478-83. PubMed ID: 16984681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of coronary rehabilitation. Ambulatory aftercare improves recovery].
    Feleke E; Perski A; Jakobsson U; Nordlander R
    Lakartidningen; 1997 Dec; 94(51-52):4903-7. PubMed ID: 9454011
    [No Abstract]   [Full Text] [Related]  

  • 14. Transradial arterial access: economic considerations.
    Caputo RP
    J Invasive Cardiol; 2009 Aug; 21(8 Suppl A):18A-20A. PubMed ID: 19734570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evidence base for the cost effectiveness of cardiac rehabilitation.
    Taylor R; Kirby B
    Heart; 1997 Jul; 78(1):5-6. PubMed ID: 9290390
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiac rehabilitation as a first step in the secondary prevention of coronary heart disease].
    Romero T
    Rev Med Chil; 2000 Aug; 128(8):923-34. PubMed ID: 11129555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical economic considerations of coronary stenting.
    Szucs TD
    Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac rehabilitation coordinators' perceptions of patient-related barriers to implementing cardiac evidence-based guidelines.
    Fernandez RS; Davidson P; Griffiths R
    J Cardiovasc Nurs; 2008; 23(5):449-57. PubMed ID: 18728518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSF for CHD: 3 years of 12-month follow-up audit after cardiac rehabilitation.
    Evans JA; Bethell HJ; Turner SC
    J Public Health (Oxf); 2006 Mar; 28(1):35-8. PubMed ID: 16251258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of statins in coronary heart disease.
    Franco OH; Peeters A; Looman CW; Bonneux L
    J Epidemiol Community Health; 2005 Nov; 59(11):927-33. PubMed ID: 16234419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.